Clinical trial
Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to…
NCT00113009 · Valentis, Industry · Completed
Key facts
| NCT number | NCT00113009 |
|---|---|
| Title | Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease |
| Official title | A Phase II, Multi-Center, Randomized, Double-Blind, Placebo Controlled Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease |
| Lead sponsor | Valentis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Disease |
| Intervention type | Drug |
| Interventions | VLTS-934 |
| Enrollment | 148 |
| Start date | Mar 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Jun 3, 2005 |
| Last update posted | Nov 22, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: